Levemir
Product Images NDC 54868-5883

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Levemir (NDC 54868-5883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levemir Flexpen Carton (5883)

Label for Levemir 100 units per milliliter Flex Pen distributed by Physicians Total Care, Inc. The label includes lot number 000 and expiration date 01/60. Manufactured by Novo Nordisk A/S in Denmark, the label features a barcode and the product NDC 54868-5883-0.*

FDA Label Image

Figure Of Chemical Structure (Ab88f81b E790 4e60 8189 8d368ac2d94b 01)

Chemical structure diagram showing the molecular composition of Levemir, an insulin analog. The diagram includes labeled amino acid sequences and side chains, highlighting disulfide bonds (S-S) and a fatty acid chain attached to the molecule. The structure is presented in a linear format with specific notation for cysteine linkages and an extended non-polar side chain.*

FDA Label Image

Figure 2: Activity Profiles In Patients With Type 1 Diabetes In A 24-hour Glucose Clamp Study (Ab88f81b E790 4e60 8189 8d368ac2d94b 02)

A pharmacodynamic graph comparing glucose infusion rates of LEVEMIR at 0.2 and 0.4 U/kg doses and NPH at 0.3 IU/kg over 24 hours after insulin injection. It includes a table of pharmacodynamic parameters AUCgIr and GIRmax for each insulin dose.*

FDA Label Image

Figure 3: Activity Profiles In Patients With Type 2 Diabetes In A 16-hour Glucose Clamp Study (Ab88f81b E790 4e60 8189 8d368ac2d94b 03)

A pharmacodynamic chart comparing glucose infusion rates (mg/kg/min) over time (hours) after insulin injection for Levemir and NPH at two dosage levels each. The graph includes a table of pharmacodynamic parameters showing area under the curve (AUC) and maximum glucose infusion rate (GIRmax) for Levemir at 0.6 and 1.2 IU/kg and NPH at 0.6 and 1.2 IU/kg.*

FDA Label Image

Figure 4a (Ab88f81b E790 4e60 8189 8d368ac2d94b 04)

A black-and-white line drawing showing hands preparing a vial and syringe for injection. The image depicts removing a cap from a vial, illustrating a step in medication preparation.*

FDA Label Image

Figure 4b (Ab88f81b E790 4e60 8189 8d368ac2d94b 05)

An instructional illustration showing a hand holding a vial and another hand preparing to insert a syringe needle into the vial's rubber stopper, demonstrating the vial preparation step for injection.*

FDA Label Image

Figure 6 (Ab88f81b E790 4e60 8189 8d368ac2d94b 06)

An instructional illustration showing hands handling a syringe with a needle cap. It depicts the process of pulling the needle cap straight off with a downward arrow, indicating how to remove the cap before use.*

FDA Label Image

Figure 7 (Ab88f81b E790 4e60 8189 8d368ac2d94b 07)

An instructional illustration showing a hand holding a vial while drawing liquid into a syringe, demonstrating proper technique for preparing an injection.*

FDA Label Image

Figure 8 (Ab88f81b E790 4e60 8189 8d368ac2d94b 08)

An instructional illustration showing a hand holding a syringe drawing liquid from a vial with an arrow indicating the motion direction. The image demonstrates how to withdraw medication from a vial using a syringe, related to the Levemir product.*

FDA Label Image

Figure 9 (Ab88f81b E790 4e60 8189 8d368ac2d94b 09)

An instructional illustration showing a hand holding a vial upside down and drawing liquid into a syringe. An arrow points downward indicating the liquid being drawn from the vial into the syringe. The image is part of a usage guide for Levemir by Physicians Total Care, Inc.*

FDA Label Image

Figure 10 (Ab88f81b E790 4e60 8189 8d368ac2d94b 10)

An instructional illustration showing two hands preparing a syringe with a vial. One hand holds the vial inverted, and the other hand is about to pierce the vial with the syringe needle, indicating the step of drawing medication into the syringe. The image is labeled with the number 10 in the top left corner.*

FDA Label Image

Figure 1 (Ab88f81b E790 4e60 8189 8d368ac2d94b 11)

An instructional illustration showing two hands injecting a subcutaneous injection with a syringe and needle. One hand holds and inserts the needle into the skin, while the other hand appears to stabilize the injection site. This image likely demonstrates the proper technique for administering Levemir.*

FDA Label Image

Figure Of Levemir Flexpen And Needle (Ab88f81b E790 4e60 8189 8d368ac2d94b 12)

An instructional diagram showing the components of the Levemir FlexPen insulin delivery device and the NovoFine needle. The FlexPen is shown disassembled with labeled parts: pen cap, rubber stopper, cartridge, cartridge scale, pointer, dose selector, and push-button. The NovoFine needle components shown are big outer needle cap, inner needle cap, needle, and protective tab.*

FDA Label Image

Figure A (Ab88f81b E790 4e60 8189 8d368ac2d94b 13)

Illustration showing the step of removing the cap from a Levemir insulin pen by pulling it straight off. The image depicts a hand holding the pen with an arrow indicating the direction to pull the cap.*

FDA Label Image

Figure B (Ab88f81b E790 4e60 8189 8d368ac2d94b 14)

An instructional illustration showing a hand holding a Levemir insulin injection pen while preparing to inject. The image highlights the step of twisting or clicking the pen to set or release the dose.*

FDA Label Image

Figure C (Ab88f81b E790 4e60 8189 8d368ac2d94b 15)

An instructional illustration showing hands connecting a needle to a pen injector device, indicating the step to attach the needle by pushing and twisting it onto the pen.*

FDA Label Image

Figure D (Ab88f81b E790 4e60 8189 8d368ac2d94b 16)

An instructional illustration showing a hand removing the cap from a pen injector device, typically used for administering medication such as Levemir. The image focuses on preparing the pen for use by pulling off the protective cap.*

FDA Label Image

Figure E (Ab88f81b E790 4e60 8189 8d368ac2d94b 17)

An instructional illustration showing a hand holding a Levemir insulin pen, with a close-up inset indicating the selection of 2 units dosage on the pen's dose selector. The image emphasizes the action of dialing the insulin dose for injection.*

FDA Label Image

Figure F (Ab88f81b E790 4e60 8189 8d368ac2d94b 18)

An instructional illustration depicting a hand pressing the injection button of a Levemir insulin pen, showing the action of delivering the dose. The image highlights user interaction with the pen device mechanism for administration.*

FDA Label Image

Figure G (Ab88f81b E790 4e60 8189 8d368ac2d94b 19)

An instructional diagram illustrating the use of a Levemir insulin pen. It shows a hand holding the pen vertically and pushing the pen button downwards, releasing insulin onto a finger, highlighting the injection process.*

FDA Label Image

Figure H (Ab88f81b E790 4e60 8189 8d368ac2d94b 20)

Illustration showing hands adjusting the dose selector on a Levemir insulin pen. The image displays 5 units and 24 units selected on the dose window, demonstrating how to set the insulin dose for injection.*

FDA Label Image

Figure I (Ab88f81b E790 4e60 8189 8d368ac2d94b 21)

An instructional illustration showing a hand pressing down on a dose selector of an insulin pen, demonstrating how to set or inject a dose on the Levemir insulin pen device.*

FDA Label Image

Figure J (Ab88f81b E790 4e60 8189 8d368ac2d94b 22)

An instructional illustration showing a syringe needle inserted into the skin, demonstrating the proper injection technique, likely related to the use of Levemir insulin.*

FDA Label Image

Figure K (Ab88f81b E790 4e60 8189 8d368ac2d94b 23)

An instructional illustration showing a hand holding a Levemir insulin pen, aligning to remove the pen cap by pulling it off as indicated by an arrow. The image focuses on how to properly remove the pen cap before use.*

FDA Label Image

Figure L (Ab88f81b E790 4e60 8189 8d368ac2d94b 24)

An illustration showing a close-up view of a pen-style medication device with a focus on the dose selector. The image highlights the number '20' on the dose window, indicating a possible set dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.